A competitive, irreversible inhibitor of Trx1; effective in suppressing the growth of cancer cells, with inhibition correlated with expression of Trx1 mRNA; reduces hypoxia-induced HIF-1α protein levels (IC50 = 7.2 μM) and expression of VEGF and iNOS; reduces microvessel density in MCF-7 tumor xenografts